Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of GNMSF will - over the next 2 Weeks and hit - by . In that time frame, GNMSF's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
GNMSF shares rose +3.79% in Friday, May 1, 2026's trading session, rising from a previous close of $255.33 to move at $265.00. The stock demonstrated notable intraday movement (see GNMSF's key stats for a full breakdown), fluctuating between $265.00 and $265.00, a 0 trading range. While recent weeks have seen some volatility, GNMSF has managed to secure a -0.82% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 16.42K shares changing hands, 16.4K more than the previous session. This amounted to $4.35M in total market activity.
Will GNMSF Continue Its Trend?
According to analyst ratings and projections for GNMSF, Genmab A/S shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for GNMSF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the GNMSF stock forecast, now is not the best time to buy GNMSF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on GNMSF covering social and institutional perspectives.
GNMSF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into GNMSF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.11% to 44.56%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.14%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.79%, maintains a neutral outlook for the long term. Insights into GNMSF's shareholder base show how institutional investors are positioning themselves during these momentum shifts

